Literature DB >> 3394572

Involvement of central histamine receptors in corticosterone secretion induced by intraventricular administration of morphine.

B Cetera1, J Bugajski, A Gadek-Michalska.   

Abstract

The effect of intracerebroventricular (i.c.v.) administration of morphine on corticosterone secretion was studied in conscious, unstressed rats. A dose-dependent increase in serum corticosterone levels was observed 1 h after morphine injection. The corticosterone response to morphine was antagonized in a dose-dependent manner, and at larger dose almost abolished, by i.c.v. pretreatment of rats with naloxone, an opioid receptor antagonist. Intraventricular pretreatment of rats with mepyramine and cimetidine, the histamine H1- and H2-receptor antagonists, significantly diminished the corticosterone response to morphine. These results suggest that central opioid receptors are involved in the stimulating effect of morphine on the hypothalamo-pituitary-adrenocortical axis. Central histamine H1- and H2-receptors seem to be substantially involved in the stimulatory effect of morphine on corticosterone secretion in conscious, unstressed rats.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3394572     DOI: 10.1007/bf02142555

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

1.  Effects of morphine upon the pituitary-adrenal system and adrenal catecholamines: a comparative study in cats and rats.

Authors:  C Guaza; A Torrellas; J Borrell; S Borrell
Journal:  Pharmacol Biochem Behav       Date:  1979-07       Impact factor: 3.533

2.  Naloxone has a direct effect on the adrenal cortex.

Authors:  J R Lymangrover; L A Dokas; A Kong; R Martin; M Saffran
Journal:  Endocrinology       Date:  1981-10       Impact factor: 4.736

3.  Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects.

Authors:  R S Rittmaster; G B Cutler; D O Sobel; D S Goldstein; M C Koppelman; D L Loriaux; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1985-05       Impact factor: 5.958

4.  Effects of morphine on hypothalamic corticotropin-releasing factor (CRF), norepinephrine and dopamine in non-stressed and stressed rats.

Authors:  S Suemaru; K Hashimoto; Z Ota
Journal:  Acta Med Okayama       Date:  1985-12       Impact factor: 0.892

5.  Effect of intraventricular histamine on hormone secretion in dogs.

Authors:  C Rudolph; G E Richards; S Kaplan; W F Ganong
Journal:  Neuroendocrinology       Date:  1979       Impact factor: 4.914

6.  Opiate effects on plasma corticosteroids: relationship to dysphoria and self-administration.

Authors:  R A Lahti; R J Collins
Journal:  Pharmacol Biochem Behav       Date:  1982-07       Impact factor: 3.533

7.  Histaminergic H1 and H2 receptors do not mediate cortisol release in response to naloxone in normal men.

Authors:  V Coiro; P Chiodera; R Volpi; G Salati; P Ferrari; A Caiazza; G Rossi
Journal:  Biomed Pharmacother       Date:  1984       Impact factor: 6.529

8.  Central H1- and H2-histaminergic stimulation of pituitary-adrenocortical response under stress in rats.

Authors:  J Bugajski; A Gadek
Journal:  Neuroendocrinology       Date:  1983-06       Impact factor: 4.914

9.  Central histaminergic stimulation of pituitary--adrenocortical response in the rat.

Authors:  J Bugajski; Z Janusz
Journal:  Life Sci       Date:  1983-09-19       Impact factor: 5.037

10.  Morphine-induced changes in histamine dynamics in mouse brain.

Authors:  M Nishibori; R Oishi; Y Itoh; K Saeki
Journal:  J Neurochem       Date:  1985-09       Impact factor: 5.372

  10 in total
  1 in total

1.  Naloxone antagonizes a central histaminergic stimulation of corticosterone secretion in rats.

Authors:  A Gadek-Michalska; J Bugajski
Journal:  Agents Actions       Date:  1988-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.